NeuroLux is proud to announce that it has been awarded a Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). The fund, totaling over $1.5M for two years, will support the development of next-generation devices that...
